NCT00643656

Brief Summary

A 50% nitrous oxide / 50% oxygen premix is administrated to the patient during the realization of liver biopsy in order to relax him and to reduce his pain during this painful medical treatment. This single investigator centre and national clinical trial is done blindly : half of patients will receive 50% nitrous oxide / 50% oxygen premix and half of them a placebo gas (mixture of 50% oxygen and 50% nitrogen). 94 patients will be included in this clinical protocol.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
94

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Oct 2007

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2007

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 19, 2008

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 26, 2008

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2008

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2008

Completed
Last Updated

March 13, 2025

Status Verified

March 1, 2025

Enrollment Period

8 months

First QC Date

March 19, 2008

Last Update Submit

March 11, 2025

Conditions

Keywords

Liver biopsy

Outcome Measures

Primary Outcomes (1)

  • Pain measurement by using Visual Analog Scale (VAS)

    At the end of the liver biospy

Secondary Outcomes (1)

  • Patient's acceptance and doctor's satisfaction

    At the end of the liver biopsy

Study Arms (2)

A

EXPERIMENTAL

Mixture of 50% nitrous oxide and 50% oxygen

Drug: Kalinox 170 bar

B

PLACEBO COMPARATOR

Mixture of 50% oxygen and 50% nitrogen

Drug: Mix of 50% oxygen and 50% nitrogen

Interventions

Flow of gas administrated to the patient between 4 and 15 litre/min and less than 1 hour

A

Flow of gas administrated to the patient between 4 and 15 litre/min and less than 1 hour

B

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patient requiring a liver biopsy of focal lesion
  • Age upper than 18 years
  • OMS : 0 to 3
  • patient consent form signed

You may not qualify if:

  • patient unable to use Visual Analog Scale (VAS)
  • OMS upper than 3
  • coagulation disorder
  • contraindication linked to the experimental product
  • patient already included in another clinical trial uncompatible with this trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beaujon hospital

Clichy, 92118, France

Location

Related Publications (1)

  • Meskine N, Vullierme MP, Zappa M, d'Assignies G, Sibert A, Vilgrain V. Evaluation of analgesic effect of equimolar mixture of oxygen and nitrous oxide inhalation during percutaneous biopsy of focal liver lesions: a double-blind randomized study. Acad Radiol. 2011 Jul;18(7):816-21. doi: 10.1016/j.acra.2011.01.025. Epub 2011 Apr 20.

    PMID: 21511500BACKGROUND

Related Links

MeSH Terms

Interventions

OxygenNitrogen

Intervention Hierarchy (Ancestors)

ChalcogensElementsInorganic ChemicalsGases

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 19, 2008

First Posted

March 26, 2008

Study Start

October 1, 2007

Primary Completion

June 1, 2008

Study Completion

December 1, 2008

Last Updated

March 13, 2025

Record last verified: 2025-03

Locations